Search results
Valrubicin-loaded immunoliposomes: A new technology to fight hematological cancer
Medical Xpress· 3 days agoValrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death ...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 18 hours agoAround 30% of MDS cases progress to acute myeloid leukemia. Even for patients who don't progress to...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 7 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 4 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Symptoms of CML Getting Worse
Healthline· 2 days agoLearn how symptoms of chronic myeloid leukemia (CML) may change as it progresses through chronic, accelerated, and blast phases.
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 3 days agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 2 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
'Smart warheads' of cancer: Experts' excitement for treatment approach grows
Becker’s Hospital Review· 6 days agoCancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody ...
How a protein component of nuclear pore complexes | Newswise
Newswise· 4 days agoNuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and...